Delta-9-tetrahydrocannabinol/cannabidiol

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Pain, cancer (adjunctive analgesia to maximum tolerated strong opioids)

Manufacturer:

GW Pharma Ltd.

Brand Name:

Sativex

Project Line:

Reimbursement Review

Project Number:

SR0106-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Resubmission

Indications:

Pain, cancer (adjunctive analgesia to maximum tolerated strong opioids)

Recommendation Type:

Do not list

Final Recommendation:

February 20, 2008

Last Updated : August 7, 2007